Mucosal and systemic immune responses to Vibrio cholerae infection and oral cholera vaccines (OCVs) in humans: a systematic review

References

• Cholera | Cholera Outbreak Response Field Manual [Internet]. [cited 2021 Oct 26]. Available from: https://choleraoutbreak.org/book-page/cholera
   Google Scholar
• SAGE Working Group on Oral Cholera Vaccines. Background paper on whole-cell, killed, oral cholera vaccines [Internet]. Who. 2017;107. Available from: https://www.who.int/immunization/sage/meetings/2017/april/OCV_Background_Document_SageWG_FinalVersion_EditedPS_.pdua=1
   Google Scholar
• Federspiel F, Ali M. The cholera outbreak in Yemen: lessons learned and way forward. BMC Public Health. 2018;18:1–8.
   Web of Science ®Google Scholar
• Clemens JD, Nair GB, Ahmed T, et al. Cholera [Internet]. The Lancet. Lancet Publishing Group. 2017. 1539–1549. cited 2020 Oct 13. Available from: http://www.thelancet.com/article/S0140673617305597/fulltext.
   Google Scholar
• Leung T, Matrajt L, Fleckenstein JM. Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: a review. PLoS Negl Trop Dis. 2021;15:e0009383.
   PubMed Web of Science ®Google Scholar
• Sur D, Deen JL, Manna B, et al The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study. Arch Dis Child. 2005;90:1175–1181.
   PubMed Web of Science ®Google Scholar
• Uddin T, Aktar A, Xu P, et al. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg. 2014;90:873–881.
   PubMed Web of Science ®Google Scholar
• Kauffman RC, Bhuiyan TR, Nakajima R, et al. Single-cell analysis of the plasmablast response to Vibrio cholerae demonstrates expansion of cross-reactive memory B cells. mBio. 2016;7. DOI:10.1128/mBio.02021-16.
   PubMed Web of Science ®Google Scholar
• Bhuiyan TR, Hoq R, Nishat S, et al. Secreting cells in whole blood from enterotoxigenic Escherichia coli - and Vibrio cholerae -infected patients. Determined Using an Enzyme. 2016;23. 27–36.
   Google Scholar
• Qadri F, Ryan ET, Faruque ASG, et al. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect Immun. 2003;71:4808–4814.
   PubMed Web of Science ®Google Scholar
• Alam MM, Riyadh MA, Fatema K, et al. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccin Immunol. 2011;18(5):844–850.
   PubMedGoogle Scholar
• Falkard B, Charles RC, Matias WR, et al. Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysacchide in Haitian adults. PLoS Negl Trop Dis. 2019;13:1–14.
   Web of Science ®Google Scholar
• McCarty JM, Lock MD, Bennett S, et al. Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial. Vaccine. 2019;37:1389–1397.
   PubMed Web of Science ®Google Scholar
• Rashu R, Bhuiyan TR, Hoq MR, et al. Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults. Microbes Infect. 2019;21:176–183.
   PubMed Web of Science ®Google Scholar
• Bourque DL, Bhuiyan TR, Genereux DP, et al. Analysis of the human mucosal response to cholera reveals sustained activation of innate immune signaling pathways. Infect Immun. 2018;86:1–17.
   Web of Science ®Google Scholar
• Olafsdottir TA, Lindqvist M, Nookaew I, et al. Comparative systems analyses reveal molecular signatures of clinically tested vaccine adjuvants. Sci Rep. 2016;6:6.
   PubMed Web of Science ®Google Scholar
• Weil AA, Ellis CN, Debela MD, et al. Posttranslational regulation of IL-23 production distinguishes the innate immune responses to live toxigenic versus Heat-Inactivated Vibrio cholerae . mSphere. 2019;4:1–14.
   Web of Science ®Google Scholar
• Repnik U, Stoka V, Turk V, et al. Lysosomes and lysosomal cathepsins in cell death. Biochim Biophys Acta Proteins Proteom. 2012;1824:22–33.
   PubMed Web of Science ®Google Scholar
• Chevriaux A, Pilot T, Derangère V, et al. Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction. Front Cell Dev Biol. 2020;8:1–8.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhong D, Chen H, et al. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. Life Sci. 2019;227:101–113.
   PubMed Web of Science ®Google Scholar
• Revu S, Wu J, Henkel M, et al. IL-23 and IL-1β drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation. Cell Rep. 2018;22:2642–2653.
   PubMed Web of Science ®Google Scholar
• Ramamurthy T, Nandy RK, Mukhopadhyay AK, et al. Virulence regulation and innate host response in the pathogenicity of Vibrio cholerae. Front Cell Infect Microbiol. 2020;10:1–22.
   PubMed Web of Science ®Google Scholar
• Kuchta A, Rahman T, Sennott EL, et al. Vibrio cholerae O1 infection induces proinflammatory CD4 + T-cell responses in blood and intestinal mucosa of infected humans. Clin Vaccin Immunol. 2011;18:1371–1377.
   PubMedGoogle Scholar
• Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2009;2:5.
   Web of Science ®Google Scholar
• Patakas A, Benson RA, Withers DR, et al. Th17 effector cells support B cell responses outside of germinal centres. PLoS One. 2012;7:1–14.
   Web of Science ®Google Scholar
• Christensen D, Mortensen R, Rosenkrands I, et al. Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses. Mucosal Immunol. 2017;10:260–270.
   PubMed Web of Science ®Google Scholar
• Ellis CN, LaRocque RC, Uddin T, et al. Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera. Infect Immun. 2015;83:1089–1103.
   PubMed Web of Science ®Google Scholar
• Aujla SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense. Semin Immunol. 2007;19:377–382.
   PubMed Web of Science ®Google Scholar
• Qadri F, Bhuiyan TR, Dutta KK, et al. Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Gut. 2004;53:62–69.
   PubMed Web of Science ®Google Scholar
• Guthridge MA, Stomski FC, Thomas D, et al. Mechanism of Activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells. 1998;16:301–313.
   PubMed Web of Science ®Google Scholar
• Lee JB, Jang JE, Song MK, et al. Intranasal delivery of cholera toxin induces Th17-dominated T-cell response to bystander antigens. PLoS One. 2009;4:(4): e5190.
   Web of Science ®Google Scholar
• Bagley K, Xu R, Ota-Setlik A, et al. The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses. Hum Vaccin Immunother. 2015;11:2228–2240.
   PubMed Web of Science ®Google Scholar
• Lavelle EC, Jarnicki A, McNeela E, et al. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J Leukoc Biol. 2004;75:756–763.
   PubMed Web of Science ®Google Scholar
• Castro Dopico X, Ols S, Loré K, et al. Immunity to SARS-CoV-2 induced by infection or vaccination. J Intern Med. 2022;291:32–50.
   PubMed Web of Science ®Google Scholar
• Majumder PP. Genomics of immune response to typhoid and cholera vaccines. Philos Trans R Soc B. 2015;370:20140142.
   PubMed Web of Science ®Google Scholar
• Losonsky GA, Yunyongying J, Lim V, et al. Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera. Infect Immun. 1996;64:10–15.
   PubMed Web of Science ®Google Scholar
• Yang JS, An SJ, Jang MS, et al. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity. PLoS One. 2019;14:1–16.
   Web of Science ®Google Scholar
• Djomo PN, Thomas SL, Fine PEM. Correlates of vaccine-induced protection: methods and implications. World Health Org [Internet]. 2013;65. Available from http://apps.who.int/iris/bitstream/10665/84288/1/WHO_IVB_13.01_eng.pdf?ua=1
   Google Scholar
• Harris JB. Cholera: immunity and prospects in vaccine development. J Infect Dis. 2018;218:S141–S146.
   PubMed Web of Science ®Google Scholar
• Aktar A, Rahman MA, Afrin S, et al. O-Specific polysaccharide-specific memory b cell responses in young children, older children, and adults infected with vibrio cholerae o1 ogawa in Bangladesh. Clin Vaccin Immunol. 2016;23:427–435.
   PubMedGoogle Scholar
• Qadri F, Helena Mäkelä P, Holmgren J, et al. Enteric infections in an endemic area induce a circulating antibody- secreting cell response with homing potentials to both mucosal and systemic tissues. J Infect Dis. 1998;177:1594–1599.
   PubMed Web of Science ®Google Scholar
• Akhtar M, Qadri F, Bhuiyan TR, et al. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country. Vaccine. 2017;35:321–328.
   PubMed Web of Science ®Google Scholar
• Uddin T, Harris JB, Bhuiyan TR, et al. Mucosal immunologic responses in cholera patients in Bangladesh. Clin Vaccin Immunol. 2011;18:506–512.
   PubMedGoogle Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11:S45.
   PubMed Web of Science ®Google Scholar
• Rappuoli R, De Gregorio E, Costantino P. On the mechanisms of conjugate vaccines. Proc Natl Acad Sci U S A. 2019;116:14–16.
   PubMed Web of Science ®Google Scholar
• Harris AM, Bhuiyan MS, Chowdhury F, et al. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun. 2009;77:3850–3856.
   PubMed Web of Science ®Google Scholar
• Patel SM, Rahman MA, Mohasin M, et al. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin Vaccin Immunol. 2012;19:842–848.
   PubMed Web of Science ®Google Scholar
• Weintraub A. Immunology of bacterial polysaccharide antigens. Carbohydr Res. 2003;338:2539–2547.
   PubMed Web of Science ®Google Scholar
• Zimmermann PC, Curtis N. Factors that influence immune response to 551 vaccination. Clin Microbiol Rev. 2019;32:1–50.
   Web of Science ®Google Scholar
• Alam MM, Leung DT, Akhtar M, et al. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine. Clin Vaccin Immunol. 2013;20:1541–1548.
   PubMedGoogle Scholar
• Chowdhury F, Khan AI, Harris JB, et al. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr Infect Dis J. 2008;27:986–992.
   PubMed Web of Science ®Google Scholar
• Leung DT, Rahman MA, Mohasin M, et al. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clin Vaccin Immunol. 2011;18:1317–1325.
   PubMedGoogle Scholar
• Arifuzzaman M, Rashu R, Leung DT, et al. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccin Immunol. 2012;19:1304–1311.
   PubMedGoogle Scholar
• Leung DT, Rahman MA, Mohasin M, et al. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clinical and Vaccine Immunology. 2012;19:5 .
   PubMedGoogle Scholar
• Leung DT, Uddin T, Xu P, et al. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccin Immunol. 2013;20:780–788.
   PubMed Web of Science ®Google Scholar
• Arifuzzaman M, Ahmed T, Rahman MA, et al. Individuals with Le(a+b-) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection. PLoS Negl Trop Dis. 2011;5:e1413.
   PubMed Web of Science ®Google Scholar
• Harris JB, la Rocque RC, Cholera and ABO blood group: understanding an ancient association. American J Tropical Med Hyg American Soc Tropical Medicine and Hygiene. 2016;95:263–264.
   PubMed Web of Science ®Google Scholar
• Qadri F, Chowdhury MI, Faruque SM, et al. Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine. 2007;25(2):231–238.
   PubMed Web of Science ®Google Scholar
• Scerpella EG, Mathewson JJ, DuPont HL, et al. Serum and intestinal antitoxin antibody responses after immunization with the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine in North American and Mexican volunteers. J Travel Med. 1996;3:143–147.
   PubMedGoogle Scholar
• Ali M, Emch M, Park JK, et al. Natural cholera infection-derived immunity in an endemic setting. J Infect Dis. 2011;204:912–918.
   PubMed Web of Science ®Google Scholar
• Harris JB, Podolsky MJ, Bhuiyan TR, et al. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl Trop Dis. 2009;3:3.
   Web of Science ®Google Scholar
• Muhsen K, Sow SO, Tapia MD, et al. Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults. Sci Rep. 2020;10:1–9.
   PubMed Web of Science ®Google Scholar
• Kosek MN, Investigators TMN, Ahmed T, et al. EBioMedicine causal pathways from enteropathogens to environmental enteropathy : findings from the MAL-ED birth cohort study. EBioMedicine. 2017;18:109–117.
   PubMed Web of Science ®Google Scholar
• Pan WK, Seidman JC, Ali A, et al. Oral polio vaccine response in the MAL-ED birth cohort study: considerations for polio eradication strategies. Vaccine. 2019;37:352–365.
   PubMed Web of Science ®Google Scholar
• Levine MM. Developing countries : lessons from a live cholera vaccine. BMC Biol. 2010;8:2–11.
   PubMed Web of Science ®Google Scholar
• Uddin MI, Islam S, Nishat NS, et al. Biomarkers of environmental enteropathy are positively associated with immune responses to an oral cholera vaccine in Bangladeshi children. PLoS Negl Trop Dis. 2016;10:8–17.
   Web of Science ®Google Scholar
• de Jong SE, Olin A, Pulendran B. The impact of the microbiome on immunity to vaccination in humans. Cell Host Microbe. 2020;28:169–179.
   PubMed Web of Science ®Google Scholar
• Levade I, Saber MM, Midani FS, et al. Predicting Vibrio cholerae infection and disease severity using metagenomics in a prospective cohort study. J Infect Dis. 2021;223:342–351.
   PubMed Web of Science ®Google Scholar
• Weil AA, Becker RL, Harris JB. Vibrio cholerae at the intersection of immunity and the microbiome . mSphere. 2019;4:6.
   Web of Science ®Google Scholar
• Venegas DP, De La Fuente MK, Landskron G, et al. Short chain fatty acids (SCFAs)mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 2019 10 10.3389/fimmu.2019.00010
   PubMed Web of Science ®Google Scholar
• Ahmed T, Svennerholm AM, Tarique A, et al. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine. 2009;27:1433–1439.
   PubMed Web of Science ®Google Scholar
• Mwanza-Lisulo M, Chomba MS, Chama M, et al. Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines. Vaccine. 2018;36:4134–4141.
   PubMed Web of Science ®Google Scholar
• Sinha R, Howlader DR, Ta A, et al. Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity. Vaccine. 2017;35:3534–3547.
   PubMed Web of Science ®Google Scholar
• Tackling Cameroon’s worst cholera outbreak in decades | gavi, the Vaccine Alliance [Internet]. cited 2022 Apr 19. https://www.gavi.org/vaccineswork/tackling-cameroons-worst-cholera-outbreak-decades.
   Google Scholar
• Global Task Force on Cholera Control [Internet]. cited 2022 Jul 28]. Available from 2022 Jul 28: https://www.gtfcc.org/.
   Google Scholar
• Larena M, Holmgren J, Lebens M, et al. Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling. J Immunol [Internet]. 2015:194;3829–3839. cited 2022 Oct 1. Available from https://pubmed.ncbi.nlm.nih.gov/25786687/
   PubMed Web of Science ®Google Scholar
• Terrinoni M, Holmgren J, Lebens M, et al. Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity. Sci Rep [Internet]. 2019;9:1–13. cited 2022 Oct 1. Available from https://www.nature.com/articles/s41598-019-38726-0
   PubMed Web of Science ®Google Scholar
• Tomic A, Tomic I, Rosenberg-Hasson Y, et al. SIMON, an automated machine learning system, reveals immune signatures of influenza vaccine responses. J Immunol. 2019;203:749–759.
   PubMed Web of Science ®Google Scholar
• M L, L A, S AM, et al. A systems biology approach identifies B Cell Maturation Antigen (BCMA) as a biomarker reflecting oral vaccine induced IgA antibody responses in humans. Front Immunol [Internet]. 2021;12. cited 2021 Oct 26. Available from https://pubmed.ncbi.nlm.nih.gov/33828557/
   Web of Science ®Google Scholar
• Tsang JS, Dobaño C, VanDamme P, et al. Improving Vaccine-Induced Immunity: can baseline predict outcome? Trends in Immunology [Internet]. 2020:41;457–465. [cited 2021 Aug 17]. Available from http://www.cell.com/article/S1471490620300661/fulltext
   PubMed Web of Science ®Google Scholar
• Pulendran B. Systems vaccinology: probing humanity’s diverse immune systems with vaccines. Proc Natl Acad Sci U S A [Internet]. 2014;111:12300–12306. cited 2022 Apr 28. Available from https://pubmed.ncbi.nlm.nih.gov/25136102/
   PubMed Web of Science ®Google Scholar